C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 110 filers reported holding C4 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,041,217 | -61.6% | 345,969 | -43.0% | 0.03% | -63.0% |
| Q3 2022 | $5,321,000 | +18.1% | 606,721 | +1.6% | 0.08% | +11.0% |
| Q2 2022 | $4,504,000 | -47.5% | 597,374 | +68.8% | 0.07% | -30.5% |
| Q1 2022 | $8,586,000 | -26.1% | 353,912 | -1.9% | 0.10% | -11.8% |
| Q4 2021 | $11,615,000 | -59.5% | 360,710 | -43.8% | 0.12% | -65.0% |
| Q3 2021 | $28,658,000 | +264.8% | 641,399 | +209.0% | 0.34% | +226.9% |
| Q2 2021 | $7,855,000 | – | 207,583 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |